The DOI matches its Crossref record.
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients1
Abstract
BACKGROUND: Induction therapy with antithymocyte globulin (ATG) reduces the incidence of acute rejection after transplantation. A study was undertaken to assess the efficacy and safety of ATG induction on tacrolimus-based and cyclosporine A (CsA)-based therapies compared with immediate tacrolimus triple therapy in kidney transplant recipients. METHODS: In a 6-month, open-label, randomized, prospective study conducted in 30 European centers, 555 renal transplant patients were randomly assigned to tacrolimus triple therapy (Tac triple, n=185), ATG induction with tacrolimus (ATG-Tac, n=186), or ATG induction with CsA microemulsion (ATG-CsA, n=184); all were combined with azathioprine and corticosteroids. The primary endpoint was incidence and time to first acute rejection episode confirmed by biopsy. RESULTS: Patient demographics and clinical parameters at baseline were similar. Patient and graft survival rates were similar in all groups. The incidence of clinically apparent acute rejection was significantly higher (P=0.003) for Tac triple (33.0%) compared with ATG-Tac (22.6%) and the incidence for ATG-Tac was significantly lower (P=0.004) than for ATG-CsA (37.0%). The incidences of acute rejection confirmed by biopsy (primary endpoint) were 25.4%, 15.1%, and 21.2% for Tac triple, ATG-Tac, and ATG-CsA, respectively (Tac triple vs. ATG-Tac, P=0.004). The incidences of corticosteroid-resistant acute rejection were 7.0% (Tac triple), 4.8% (ATG-Tac), and 10.9% (ATG-CsA) (ATG-Tac vs. ATG-CsA, P=0.038). In the ATG groups, the incidences of leukopenia, thrombocytopenia, serum sickness, fever, and cytomegalovirus infection were significantly higher (P<0.05). CONCLUSIONS: Acute rejection was significantly lower in the ATG-Tac group compared with the ATG-CsA and Tac triple groups. Significantly more hematologic and infectious adverse events were observed in both ATG induction groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
Eckardt, K.-U., Kasiske, B. L., & Zeier, M. G. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02834.x · Cited by 1,499
Drug Allergy: An Updated Practice Parameter
(2010) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2010.08.002 · Cited by 957
Therapeutic Monitoring of Calcineurin Inhibitors for the Nephrologist
Schiff, J., Cole, E., & Cantarovich, M. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03791106 · Cited by 257
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients
Hill, P., Cross, N. B., Barnett, A. N. R., Palmer, S. C., & Webster, A. C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004759.pub2 · Cited by 135
Claes, K., Meier-Kriesche, H.-U., Schold, J. D., Vanrenterghem, Y., Halloran, P. F., & Ekberg, H. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr238 · Cited by 75
“[15] have already demonstrated that hypercholesterolaemia occurs more frequently during treatment with CsA than during treatment with Tac.”
Background
Metadata
- Authors
- Charpentier, B., Rostaing, L., Berthoux, F., Lang, P., Civati, G., Touraine, J.-L., Squifflet, J.-P., Vialtel, P., Abramowicz, D., Mourad, G., Wolf, P., Cassuto, E., Moulin, B., Rifle, G., Pruna, A., Merville, P., Mignon, F., Legendre, C., Le Pogamp, P., Lebranchu, Y., Toupance, O., Hurault de Ligny, B., Touchard, G., Olmer, M., Purgus, R., Pouteil-Noble, C., Glotz, D., Bourbigot, B., Leski, M., Wauters, J.-P., & Kessler, M.
- Venue
- Transplantation
- Published
- 2003-03
- Volume
- 75
- Issue
- 6
- Pages
- 844-851
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2027511687
- Cited by
- 162
- References
- 0
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients1. https://app.cochat.ai/papers/10.1097/01.tp.0000056635.59888.ef
- The paper
- Charpentier, B., Rostaing, L., Berthoux, F., Lang, P., Civati, G., Touraine, J.-L., Squifflet, J.-P., Vialtel, P., Abramowicz, D., Mourad, G., Wolf, P., Cassuto, E., Moulin, B., Rifle, G., Pruna, A., Merville, P., Mignon, F., Legendre, C., Le Pogamp, P., . . . Kessler, M. (2003). A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients1. Transplantation. https://doi.org/10.1097/01.tp.0000056635.59888.ef
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.